Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Diabetes
|
July 13, 2022
PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo
Edwige Schreyer, Cathy Obringer, Nadia Messaddeq, et al.
Diabetes Care
|
October 27, 2017
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
John R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Diabetes Care
|
March 18, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
Lutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia
|
March 19, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
Lutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia
|
December 6, 2019
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
G Alexander Fleming, John R Petrie, Richard M Bergenstal, et al.
Diabetes Care
|
December 7, 2019
Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
G Alexander Fleming, John R Petrie, Richard M Bergenstal, et al.
Diabetologia
|
October 26, 2017
Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
John R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Current Diabetes Reviews
|
April 14, 2016
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
Clinical Therapeutics
|
April 18, 2017
Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action
Irl B Hirsch, Joe Martinez, E Ray Dorsey, et al.
Expert Opinion on Pharmacotherapy
|
November 10, 2022
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study
Harold E Lebovitz, Alexander Fleming, Alan D Cherrington, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Diabetes
|
July 13, 2022
PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo
Edwige Schreyer, Cathy Obringer, Nadia Messaddeq, et al.
Diabetes Care
|
October 27, 2017
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
John R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Diabetes Care
|
March 18, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
Lutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia
|
March 19, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
Lutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia
|
December 6, 2019
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
G Alexander Fleming, John R Petrie, Richard M Bergenstal, et al.
Diabetes Care
|
December 7, 2019
Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
G Alexander Fleming, John R Petrie, Richard M Bergenstal, et al.
Diabetologia
|
October 26, 2017
Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
John R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Current Diabetes Reviews
|
April 14, 2016
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
Clinical Therapeutics
|
April 18, 2017
Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action
Irl B Hirsch, Joe Martinez, E Ray Dorsey, et al.
Expert Opinion on Pharmacotherapy
|
November 10, 2022
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study
Harold E Lebovitz, Alexander Fleming, Alan D Cherrington, et al.
Page
of 8